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Mapping and validation of a major QTL affecting resistance
to pancreas disease (salmonid alphavirus) in Atlantic salmon
(Salmo salar)
S Gonen1,7, M Baranski2,7, I Thorland3, A Norris4, H Grove5, P Arnesen4, H Bakke6, S Lien5, SC Bishop1
and RD Houston1
Pancreas disease (PD), caused by a salmonid alphavirus (SAV), has a large negative economic and animal welfare impact on
Atlantic salmon aquaculture. Evidence for genetic variation in host resistance to this disease has been reported, suggesting that
selective breeding may potentially form an important component of disease control. The aim of this study was to explore the
genetic architecture of resistance to PD, using survival data collected from two unrelated populations of Atlantic salmon; one
challenged with SAV as fry in freshwater (POP 1) and one challenged with SAV as post-smolts in sea water (POP 2). Analyses of
the binary survival data revealed a moderate-to-high heritability for host resistance to PD in both populations (fry POP 1 h2 ~0.5;
post-smolt POP 2 h2 ~0.4). Subsets of both populations were genotyped for single nucleotide polymorphism markers, and six
putative resistance quantitative trait loci (QTL) were identiﬁed. One of these QTL was mapped to the same location on
chromosome 3 in both populations, reaching chromosome-wide signiﬁcance in both the sire- and dam-based analyses in POP 1,
and genome-wide signiﬁcance in a combined analysis in POP 2. This independently veriﬁed QTL explains a signiﬁcant proportion
of host genetic variation in resistance to PD in both populations, suggesting a common underlying mechanism for genetic
resistance across lifecycle stages. Markers associated with this QTL are being incorporated into selective breeding programs to
improve PD resistance.
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INTRODUCTION
Infectious diseases present a signiﬁcant threat to the sustainability of
Atlantic salmon aquaculture (Wheatley et al., 1995; McLoughlin et al.,
2002). Pancreas disease (PD), an alphaviral disease, is one of the most
problematic infectious diseases, and causes high levels of mortality and
morbidity on farms (FAO, 2013). Six subtypes of the PD-causing
salmonid alphavirus (SAV) have been isolated in different parts
of the world, including Scotland, Norway and Chile (Fringuelli
et al., 2008). Subtypes are geographically speciﬁc, and farms within
the same locality typically show infection with the same subtypes
(Kristoffersen et al., 2009; Graham et al., 2012). For example, the two
SAV subtypes in Norway (SAV2 and SAV3) have been shown to affect
distinct sites (SAV2 in the north and SAV3 mainly in the south of
Norway), with no overlap or co-infection within sites (Hjortaas et al.,
2013; Jansen et al., 2014).
Natural infections with SAV have only been documented in the
post-smolt stage of the salmon lifecycle, shortly after transfer from
freshwater to sea water. Infection with SAV has been shown to result
in histological changes in the heart, skeletal muscle and the pancreas of
post-smolt salmon, as well as causing signs of morbidity such as a
loss of appetite and lethargy (McLoughlin et al., 2002; Rodger and
Mitchell, 2007; Taksdal et al., 2007). Response to infection may be
inﬂuenced by many factors, such as feeding rate, season, temperature,
stocking density, co-infection with other pathogens and host genetics
(McLoughlin et al., 2002; Rodger and Mitchell, 2007; Graham et al.,
2008; Norris et al., 2008; Kristoffersen et al., 2009; Jansen et al., 2010a;
Stene et al., 2013). Long-term subclinical infections are common, and
the peak in mortalities associated with a PD epidemic is often seen
many months after infection (Karlsen et al., 2012). Survivors of
infection can show chronic long-term illness and a reduced growth
rate, leaving them vulnerable to infection with other pathogens and
thus with drastically reduced economic value (Fringuelli et al., 2008).
Management techniques currently employed to prevent the spread
of the virus and reduce morbidity and mortality levels include site
fallowing, site hygiene measures and vaccination. A variety of vaccine
types targeting the different SAV subtypes have been tested. However,
these have shown a substantial variation in efﬁcacy in test populations,
suggesting a complex, multifactorial basis for protection (Rodger and
Mitchell, 2007; Jansen et al., 2010a; Karlsen et al., 2012; Graham et al.,
2014; Jansen et al., 2014). Consequently, there is a need for additional
methods to complement or enhance current control measures, such as
breeding salmon that are more resistant to PD.
Family-based selection for disease resistance, as a disease control
strategy, has been an ongoing part of several Atlantic salmon breeding
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programs, with promising improvements in resistance seen for several
diseases (Fjalestad et al., 1993; Storset et al., 2007). This strategy
exploits the between-family genetic variation in resistance, where
breeding candidates are selected based on performance of their siblings
and other relatives in a disease challenge (Gjedrem, 1985; Gjøen and
Bentsen, 1997). While effective, this approach ignores within-family
variation, hence, will be less effective than approaches that utilise both
within- and between-family genetic variation (Falconer and Mackay,
1996; Meuwissen and Goddard, 1996). For resistance (and other traits
of economic value), the within-family variation can be exploited
through the use of genetic markers as part of genomic or marker-
assisted selection (GS and MAS respectively) in breeding programs.
Both strategies require the identiﬁcation of quantitative trait loci
(QTL)-linked markers, which are used to identify the most resistant
individuals within families (Meuwissen and Goddard, 1996). MAS is
currently being implemented to increase host resistance to infectious
pancreatic necrosis in Atlantic salmon breeding programs (Houston
et al., 2008; Moen et al., 2009; Houston et al., 2010, 2012), and the
potential of within-family GS using the large full-sibling families in
aquaculture breeding programs is being explored (Sonesson and
Meuwissen, 2009; Nirea et al., 2012).
Resistance to PD in Atlantic salmon has been shown to be
moderately heritable (h2= 0.21 (Norris et al., 2008)), hence, it is
possible to apply family-based selection for enhanced PD resistance.
However, as described above, improvements in selection accuracy, and
therefore genetic gain, could be achieved through the use of genetic
markers to capture within-family variation in resistance. Therefore, it
is important to determine the genetic architecture of PD resistance and
locate major QTL as candidates for MAS. Further, with reference
genome sequences for salmonid species now available (Davidson et al.,
2010; Berthelot et al., 2014), identiﬁcation of genes underlying these
major QTL may lead to an improved understanding of the biology of
viral resistance in salmonid species.
The overall aim of this study was to explore the genetic architecture
of PD resistance in Atlantic salmon, at both the fry and post-smolt
stages. The speciﬁc aims of this study were to: (i) estimate the
heritability of resistance to PD in large populations of Atlantic salmon
fry and post-smolts challenged with SAV; (ii) detect and position
QTL-inﬂuencing resistance to PD; and (iii) identify markers in
population-level association with the resistance QTL, for potential
use in MAS in these populations.
MATERIALS AND METHODS
Experimental populations
This manuscript describes two PD challenge studies carried out independently
by two research groups in distinct populations of Atlantic salmon. One
population was challenged as fry in freshwater and the other as post-smolts
in sea water. As such, the population details, challenge protocol and analysis
methodology have some speciﬁcities for each study. The ﬁrst population (POP
1) consisted of 5558 Atlantic salmon fry from 218 full-sibling (FS) (83 paternal
half-sibling; HS) families (~25 fry per FS family), from the 2010 year class of
Marine Harvest. The Marine Harvest ﬁsh stock originates from the Mowi strain
from the River Bolstad and the River Aaroy in Norway. Breeding programs
using founder populations from these two rivers were established in the 1960 s
(for further details, see Glover et al. (2009)). The second population (POP 2)
consisted of 4946 post-smolts from 284 FS (120 paternal HS) families (~17
post-smolt per FS family) from the 2009 year class of SalmoBreed AS. The
founding populations of the SalmoBreed ﬁsh stock originate from the Bolaks
and Jakta strains, and breeding programs were established in the 1970 s
(see http://www.salmobreed.no/en/about/company-history). Therefore, the two
challenge populations have distinct genetic backgrounds.
SAV challenges
Both populations (POP 1 and POP 2) were challenged with the same strain of
SAV, SAV3, which is the most abundant strain in Norway (Hodneland et al.,
2005). However, due to the different lifecycle stages of the populations, the
challenge protocols were different. Both challenge experiments were carried out
in accordance with guidelines from the Norwegian Animal Research Authority
by VESO Vikan, Norway (POP 1) and PHARMAQ AS, Norway (POP 2).
In the POP 1 challenge, fry at 51 days post hatch (average weight: 0.5 g) were
starved for 24 h prior to challenge. The challenge protocol used was as follows:
100 Atlantic salmon parr (‘shedders’; average weight ~ 38 g) were infected with
SAV3 using an intraperitoneal injection. The viral challenge dose was 3.3e5
TCID50 per shedder. Infected parr were kept in a tank of 216 l in volume and
were allowed to shed virus into this tank for one week. Efﬂuent water from this
tank was passed into a single fry challenge tank of 10 l in volume. Water
temperature in this fry challenge tank was maintained at 12 °C and water ﬂow
was 41 l Kg− 1min− 1 to ensure 475% O2 saturation in water efﬂuent. The
challenge commenced on 15 June 2010 and continued until mortalities were
negligible (end date: 11 August 2010). Ten fry from the main mortality period
(that is, after 410% mortality was obtained) were sampled and measured for
viral load (quantitative PCR). The total mortality level at the end of the
challenge was 3456 (60%) (Figure 1a). Mortalities were removed from the tank
daily, whereas survivors were collected and euthanized at the end of the
experiment (in accordance with guidelines from the Norwegian Animal
Research Authority). Tissue samples from both mortalities and survivors were
stored at − 20 °C. For all further analyses conducted in POP 1 (including
parentage assignment), PD mortalities were deﬁned as those which occurred
between dates 5 July 2010 (21 days post challenge) and 04 August 2010 (8 days
prior to challenge termination) (Figure 1a).
In the POP 2 challenge, post-smolts at body weight ~ 85 g and 333 days post
hatch were infected with SAV3 by means of direct intraperitoneal injection.
Each ﬁsh was injected with 0.1ml of the SAV3 virus isolate provided by
PHARMAQ AS (see Karlsen et al. (2012) for further details). Injected test ﬁsh
were kept in saltwater in a single 4m diameter tank for the duration of the
challenge. The water temperature was maintained at 12 °C. Water ﬂow was
41.7 l kg− 1min− 1 and was continuously adjusted to ensure 480% oxygen
saturation in water efﬂuent. The challenge commenced on 7 December 2009
and continued until mortalities were negligible (end date: 22 December 2009).
The total mortality at the end of the challenge was 3058 (62%) (Figure 1b).
Mortalities were recorded and sampled once daily, and survivors were collected
and euthanized at the end of the experiment (in accordance with guidelines
from the Norwegian Animal Research Authority). Ventricle samples from 20
mortalities from day 9 to day 14 post challenge were sent for real-time PCR to
detect the presence of SAV and quantify viral load. Tissue samples from each
ﬁsh were taken and stored at − 20 °C for subsequent DNA extraction and
genotyping. For all further analyses, PD mortalities were deﬁned as those
occurring between 7 days post challenge, where the mortality level rose
substantially above baseline levels, to the end of the epidemic (16 days post
challenge), when mortalities were negligible.
Parentage assignment
As the challenged fry in POP 1 were too small to be tagged (for example, using
an electronic passive integrated transponder (PIT) tag), parentage assignment of
surviving and mortality offspring was undertaken by genotyping. Survivors
were genotyped using a panel of nine microsatellite loci and assigned to family
(GenoMar, Co/Glastad Invest AS, Fridtjof Nansens Plass 3, Oslo, Norway).
Parentage assignment of mortalities was carried out at The Roslin Institute
using a panel of 87 single-nucleotide polymorphisms (SNPs) distributed across
all chromosomes (taken from Moen et al. (2008)). Eighteen of these failed the
genotyping assay or were uninformative, thus 69 SNPs remained for further
analyses (Supplementary Table 1) (genotyping was performed by LGC
Genomics Ltd, Herts, EN11 0WZ, UK). Three software packages were used
for parentage assignment of mortalities: SNPPIT (maximum likelihood
algorithm) (Anderson, 2010), FAP (genotype exclusion algorithm) (Taggart,
2007) and Vitassign (genotype exclusion algorithm) (Vandeputte et al., 2006).
Successful parentage assignment of mortalities was taken only if agreement was
seen between outputs from at least two of the software.
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In POP 2, all ﬁsh were individually PIT tagged prior to the mixing of families
(at ~ 19 g body weight) and, therefore, PIT tag scanning of surviving and
mortality ﬁsh was used for family assignment.
Quantitative genetic parameter estimation
POP 1–PD resistance of fry. One hundred and ﬁfty FS families (72 HS families;
72 sires and 150 dams; parents were not closely related) with 415 offspring
(total of survivors and mortalities; average mortality per family: 61%; Figure 1c)
were selected for estimation of genetic parameters, that is, the additive genetic
variation and heritability for PD resistance. Variance components were
estimated by ﬁtting the following linear mixed model in the ASReml software
(Gilmour et al., 2009):
Y ijk ¼ mþ Si þ Dij þ eijk ð1Þ
where Yijk is the observed SAV challenge outcome for individual k with sire i
and dam j; μ is the population mean; Si and Dij are the random additive genetic
effects of the ith sire and jth dam; and eijk is the residual variance. Sire and Dam
were ﬁtted as random effects and assumed to be normally distributed, with
variances σ2S and σ
2
D, respectively. The total additive genetic variance was
estimated as 2(σ2S+σ
2
D). Common environmental effects associated with FS
family were not signiﬁcant, hence, this effect was not ﬁtted.
As challenge outcome was scored as a binary variable (survived or died), the
heritability of PD resistance was estimated on the observed binary scale, and
also by using a logit-link or probit-link function to account for the binary data.
Assuming a continuous underlying liability for the binary challenge outcome,
the observed binary scale heritability (h201) was converted to the underlying
liability scale using the formula (from Falconer and Mackay (1996)):
h2 ¼ h201ð1 pÞ=i2p ð2Þ
where p is the proportion of dead individuals in the dataset, and i is the mean
deviation (in s.d. units) from the population mean of the highest ranking p
individuals, assuming a normal distribution.
POP 2–PD resistance of post-smolts. Estimation of genetic parameters in POP 2
was conducted using all 284 FS families described in the challenge
protocol above. Twenty-nine mortalities which occurred prior to day 7 of
the challenge were excluded as they occurred before the PD outbreak
(Figure 1b). As in POP 1, the trait analysed was binary PD challenge outcome
(survived or died) at the challenge termination date. Two models were applied
to estimate variance components using the ASReml software (Gilmour et al.,
2009). Model 1 was an animal linear model:
Y ij ¼ mþ btwi þ ai þ cj þ eij ð3Þ
where Yij is the observed survival status in the challenge test of individual i from
FS family j; μ is the population mean; twi is the body weight of individual i at
tagging; β is a ﬁrst degree ﬁxed regression coefﬁcient of survival on twi; ai is the
random additive genetic effect of individual i; cj is the random effect common
to FS family j other than additive genetics (that is, environmental effect of
common rearing tank prior to PIT tagging, non-additive genetic effects, and
maternal effects); and eij is the individual random residual effect.
Model 2 was a linear sire-dam model:
Y ijk ¼ mþ btwi þ Sj þ Djk þ cjk þ eijk ð4Þ
where Yijk is the observed survival status in the challenge test of individual i in
FS family jk with sire j and dam k; and Sj and Djk are the random effects of the
jth sire and kth dam. As sires and dams were selected from the same
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Figure 1 Mortality proﬁles. (a) POP 1 (fry)—number of mortalities observed
per day over the course of the challenge, from 18 days post challenge
(2 June 2010—prior to which mortalities were negligible) to the challenge
termination date (11 August 2010). The peak in mortalities was observed
28 days post challenge. For all analyses in POP 1, mortalities between dates
5 June 2010 (21 days post challenge) and 4 August 2010 (51 days post
challenge) were assumed to be due to PD, and the mortality proﬁle within
this time frame is indicated by the dotted red lines. (b) POP 2 (post-smolts)
—number of mortalities observed per day over the challenge duration. The
peak in mortalities occurred on day 13 post challenge. Further analyses in
POP 2 were conducted using mortalities which occurred 7 days post
infection; these mortalities are highlighted by the dotted red lines. (c) POP 1
(fry)—the number of full-sibling families across the 150 full-sibling families
with a given percentage mortality. Family mortality ranged from 0 to 100%,
with an average mortality of 61%. These families were used to estimate the
heritability of resistance to PD. (d) POP 2 (post-smolts)—total number of
full-sibling families with a given percent mortality. Family mortality ranged
from 5 to 100%, with an average family mortality of 62%.
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population, the sire and dam additive genetic variances (σ2S and σ
2
D,
respectively) were constrained to be equal (σ2S= σ2D=¼σ2a). From model 1,
the heritability was estimated as follows:
h2 ¼ s2a=s2p ð5Þ
whereas in model 2 it was estimated as:
h2 ¼ 4s2s=s2p ð6Þ
In both cases, the non-additive effect common to FS was estimated as:
c2 ¼ s2c=s2p ð7Þ
where σ2a is the additive genetic variance, σ
2
S is the additive genetic sire
variance, σ2c is the non-additive variance common to FS; σ
2
e is the residual
variance; and σ2p= σ2a+σ2c+σ2e for results from model 1 and σ2p= 2σ2S+σ2c
+σ2e for results from model 2. As in POP 1, heritabilities on the observed
binary scale obtained in both model 1 and model 2 were converted on to the
underlying liability scale, to account for the binary format of challenge
outcome. In addition to this, model 2 was ﬁtted on the probit scale, using
the probit-link function in ASReml.
Genotyping for QTL mapping
For POP 1, a two-step QTL mapping strategy was employed to utilise the
disparity in recombination rate between the sexes in Atlantic salmon (Hayes
et al. (2006); Houston et al. (2008); described in more detail below). QTL
detection was performed using a sparse SNP panel and sire-based mapping,
whilst QTL conﬁrmation and estimation of position was performed using a
denser SNP panel and dam-based mapping. From the 150 FS families used for
estimation of genetic parameters, 20 paternal HS families (55 FS families) with
intermediate levels of mortality (range: 45–72%) were selected for QTL
mapping. Survivors from these families were identiﬁed, their genomic DNA
was extracted (using the Qiagen DNeasy 96 protocol Blood & Tissue kit), and
genotyped (by LGC Genomics Ltd) for the same sparse SNP panel used for
parentage assignment of mortalities (Supplementary Table 2). One hundred
and seventy-seven survivors (28%) with poor quality genotyping information
(excess missing genotypes or Mendelian errors given expected family assign-
ment conducted using the microsatellite panel) were removed from the QTL
mapping analysis.
In POP 2, genomic DNA was extracted from ﬁn and muscle samples of 1182
parents and offspring, using a modiﬁed high-salt precipitation protocol (http://
www.genomics.liv.ac.uk/animal/RESEARCH/ISOLATIO.PDF). DNA was quan-
tiﬁed using the PicoGreen double-strand DNA quantitation assay (Invitrogen,
Life Technologies LTD, Paisley, UK), and DNA concentrations normalised
to 50 ng µl− 1. Genotyping was carried out according to the manufacturer's
instructions, using the 6 K Atlantic salmon Illumina iSelect SNP array
developed by the Centre for Integrative Genetics (www.cigene.no). Genotype
data were quality-checked using Genome Studio (Illumina Inc, San Diego, CA,
USA) and were ﬁltered to achieve a 95% call rate for both samples and SNPs.
SNPs were ﬁltered to retain those with MAF42.5%. The remaining 5278 SNPs
were further ﬁltered to remove those with low quality and those with a MAF of
o1%, leaving 4178 SNPs for subsequent analyses.
QTL mapping
For both populations, QTL mapping was conducted in the GridQTL software
(Allen et al., 2012) using two methods. First, taking advantage of the large
paternal HS families, a HS analysis was conducted in both populations
independently, which uses a linear regression-based interval mapping approach
to QTL identiﬁcation (for details, see Knott et al. (1996)). In brief, using a
multiple marker-based approach, the probability of inheriting a particular allele
at a particular marker location is calculated and used to estimate the
information content for each marker. At each centiMorgan (cM) interval, the
phenotypes (binary challenge outcome) are regressed on the probabilities of
inheriting particular alleles. The strength of evidence for a QTL is calculated,
expressed as an F ratio, with the numerator degrees of freedom equal to the
number of parents that are informative at a given chromosome (Knott et al.,
1996). To determine whether the estimated QTL F ratio was signiﬁcant (that is,
whether the identiﬁed QTL was signiﬁcantly inﬂuencing resistance) at the
chromosome- and/or genome-wide level, chromosome- and genome-wide
critical F ratios were calculated using permutation testing in the GridQTL
software, as follows. The chromosome-wide critical F ratio threshold was
determined using 10 000 permutations in both populations. A genome-wide
critical F ratio threshold was calculated by ﬁrst obtaining a Bonferroni corrected
P-value at the 5% signiﬁcance level (given the 29 pairs of chromosomes of
Atlantic salmon, adjusted P-value= 0.05/29) and then obtaining the
genome-wide F ratio threshold at this adjusted P-value, using 10 000 permuta-
tions (Churchill and Doerge, 1994). The QTL F ratio was compared
with the chromosome- and genome-wide critical F ratio, and if the QTL F
ratio was larger than either one of these, then this QTL was determined as
signiﬁcantly affecting PD resistance in this population. For each genome-wide
signiﬁcant QTL, conﬁdence intervals for the location parameter were estimated
using the bootstraps with resampling method and 10 000 iterations (Visscher
et al., 1996).
Second, to exploit the FS data set structure in both populations (family sizes
of 15–29 offspring in POP 1 and 4–37 offspring in POP 2), QTL mapping was
also conducted in both populations independently using a sib-pair (SP)
approach, implemented in the GridQTL software. This approach is based on
the principle that FS who inherit more QTL alleles identical-by-descent (IBD)
tend to be more similar in phenotype, that is, the difference between their
phenotypes tends to be smaller the more QTL alleles they share IBD (Haseman
and Elston, 1972). IBD probabilities are ﬁrst calculated at 1 cM intervals, and the
residuals from this analysis are then used in a Haseman–Elston approach, in
which the squared difference of the phenotypes (that is, residuals) is regressed
on to the IBD probabilities (Haseman and Elston, 1972; Knott and Haley,
1998). QTL signiﬁcance and conﬁdence intervals in both populations was
determined using permutation testing, as described for the HS analysis above.
The proportions of within-family variance explained (PVE) by each
signiﬁcant QTL were estimated using the HS analyses in GridQTL, and the
following formulae. For the sire- or dam-based linkage analysis: h2QTL= 4[1-
(MSEfull/MSEred)]; for the combined sire- and dam-based linkage analysis:
h2QTL= 2[[1-(MSEfull/MSEred)SIRE]+[1-(MSEfull/MSEred)DAM]]; where MSEfull
and MSEred are the mean square errors for the models with and without the
QTL, respectively.
Despite the similarity of the statistical methods used to identify QTL,
different genotyping approaches were implemented in the two different
populations. Therefore, some details of the QTL-mapping analyses were
population-speciﬁc, and these are described below.
The HS QTL-mapping analysis in POP 1 was carried out using a two-step
approach (Hayes et al., 2006; Houston et al., 2008), which takes advantage of
the large disparity in recombination rates between Atlantic salmon males and
females. The low recombination rate in males means that the inheritance of
large sections of the genome from sire to offspring can be tracked by
genotyping individuals using a sparse marker set. This allows the identiﬁcation
of chromosomes harbouring QTL signiﬁcantly inﬂuencing the trait of interest
(step one). Signiﬁcant QTL can then be positioned on chromosomes by
genotyping a denser set of markers only for the signiﬁcant chromosomes, and
following the inheritance patterns of these markers from dams to offspring
(step two).
This two-step approach for QTL identiﬁcation was applied in POP 1, using
1273 offspring (463 survivors, 810 mortalities) belonging to 20 paternal HS (55
FS) families (HS family size range: 41–90 offspring; average= 64) with
intermediate levels of mortality (mortality range 40–70%). Assuming QTL of
intermediate frequency, the use of paternal HS families with intermediate
mortality levels should, in principle, increase the power for the detection of
QTL segregating within families. A dam-linkage analysis using the same
approach and sparse SNP panel (55 dams, resulting in 55 FS families, with
average size 23 offspring per family) was also conducted to identify QTL
segregating in dams but not sires, recognising that dam-segregating QTL may
be missed with sparse markers. In the second step of QTL mapping, a denser
set of SNP markers (36 in total, taken from Lien et al. (2011) and Gonen et al.
(2014) and including the sparse marker panel used in step one; Supplementary
Table 2) was genotyped for chromosomes identiﬁed as containing QTL at
chromosome- or genome-wide signiﬁcance in step one. Linkage maps for these
chromosomes were constructed using the Lep-MAP software (Rastas et al.,
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2013) (Supplementary Table 2). Using this denser set of mapped SNPs, a dam-
based linkage analysis was conducted to test for the presence of QTL and to
estimate their position on the chromosome. The SP analysis in POP 1 was ﬁrst
conducted for all 29 chromosomes using the sparse set of SNP markers. For
chromosomes with the denser set of markers genotyped (that is, were
signiﬁcant in the sire-based HS analysis), the SP analysis was repeated using
the denser set of SNPs.
In POP 2, male and female mapping parents were used in a combined ‘HS’
analysis. To convert the genotype data sets into a format compatible with the
GridQTL mapping software, each data set was duplicated prior to analysis, with
the designation of parents as sire or dam inverted in the duplicate. All analyses
were carried out using the genetic map produced by Lien et al. (2011), with the
exception of chromosome 3; the chromosome for which a genome-wide
signiﬁcant QTL was identiﬁed. For this chromosome, a separate map was
produced based on the data generated within this study using CRIMAP
(version 2.4 (Green et al., 1990), modiﬁed by Xuelu Liu (Monsanto)), and the
results for this chromosome are referred to relative to this map.
Association analysis
A genome-wide association analysis between SNP markers and PD mortality
was performed in POP 2 (where the 6K Atlantic salmon SNP array was used for
genotyping). The quality-ﬁltered 4178 SNPs (retaining those of high quality and
MAF41%) were used to conduct an association analysis in the GenABEL
software package (Aulchenko et al., 2007). Following the recommended
procedure from the software manual, inﬂation caused by stratiﬁcation was
calculated, and when the inﬂation measurement was different from 1, the
pedigree kinship matrix was calculated and ﬁtted to the data, using the function
‘polygenic()’. The residuals from the 'polygenic()' function were then used as
input (without covariates) to the 'qtscore()' function for the association
analysis. The ‘qtscore()’ function implements the association test ‘Genome-
wide Rapid Analysis using Mixed Models And Score’ (GRAMMAS, Amin et al.
(2007)). Test signiﬁcance was reported as both the P-values calculated by the
package individually for each SNP, and also adjusted P-values based on
permutation tests to empirically estimate the genome-wide signiﬁcance. In
POP 1, individual SNPs on the QTL-containing chromosomes were also tested
for association with PD resistance, using the software package ASReml
(Gilmour et al., 2009). The SNP association was conducted by ﬁtting the same
mixed model used to estimate the heritability, with the added step of ﬁtting
each SNP individually as a ﬁxed effect.
RESULTS
Challenge outcomes and parentage assignment
For all analyses conducted in POP 1, mortalities between 21 and
51 days post challenge were assumed to be due to PD, as described
above. Overall, 3456 mortalities were observed, 3415 of which were
designated as PD mortalities. Of these, 2455 were successfully assigned
to 71 HS (157 FS) families. 2328 survivors remained at the challenge
termination date (11 August 2010) (Figure 1a), 2102 of which were
successfully assigned back to 81 HS (203 FS) families.
In the post-smolt challenge (POP 2), mortalities occurred over a
much shorter period, hence the trial duration was shorter (Figure 1b).
Overall, 3058 mortalities and 1888 survivors were observed across
the 16-day challenge (7 December 2009 to 22 December 2009). All
survivors and 3029 mortalities occurring 7 days post infection (14
December 2009 to 22 December 2009) were included in subsequent
analyses. Real-time PCR results of the 20 sampled mortalities were all
positive for PD virus (Ct range 15.0–19.5). Given that each ﬁsh had
been individually PIT tagged prior to challenge, parentage assignment
by genotyping was not required.
Estimated heritabilities
The heritability for PD resistance in POP 1 was estimated using 72 HS
(150 FS) families with 15 or more offspring (3949 offspring in total,
2367 mortalities, 1582 survivors). Mortalities in these families ranged
from 0 to 100%, with an average mortality of 61% (Figure 1c). The
heritability of PD resistance across these families was estimated at 0.34
on the observed binary scale, which equated to ~0.5 on the underlying
liability scale (Table 1), and this estimate was relatively consistent
across the different models (underlying liability, logit-link and probit-
link models). Non-genetic effects associated with family were not
signiﬁcant.
In POP 2, heritability estimates were obtained from a data set
consisting of 4917 individuals belonging to 284 FS families. The
average mortality per FS family at the challenge termination date was
62% (Figure 1b), and mortalities per family ranged from 5 to 100%
(Figure 1d). Using these families, heritabilities of 0.26 and 0.23 were
estimated on the observed binary scale using two models: Model 1—
Animal model; Model 2—Sire-dam model (Table 1). As with POP 1,
these heritabilities were transformed on to the underlying liability
scale, and a heritability of ~ 0.4 was obtained using both models
(Table 1). Fitting model 2 on the probit-link scale resulted in a
heritability estimate of 0.33, which is consistent with the underlying
liability scale heritability estimate of 0.37 (Table 1). Estimated effects
common to FS other than additive genetics were small (range: 0.03–
0.05; Table 1) and not signiﬁcant.
QTL mapping
In POP 1, QTL were identiﬁed by applying a two-step mapping
approach in the HS analysis, using a sparse then a denser SNP panel,
and further taking advantage of the unequal recombination rates
between males and females (described in Materials and Methods). The
initial sire-linkage analysis using a sparse SNP panel identiﬁed three
putative QTL affecting PD resistance, on chromosomes 3, 7 and 23
(Table 2). The QTL on chromosome 23 was signiﬁcant at the genome-
Table 1 Estimated heritabilities for PD resistance in both populations, for each model and method of analysis
Population Model Method Heritability (± s.e.) Common environmental effects (± s.e.)
POP 1 Sire-dam Observed binary scale 0.34 (±0.05) NA
Underlying liability scale 0.55 NA
Probit-link scale 0.54 (±0.07) NA
Logit-link scale 0.46 ( 0.06) NA
POP 2 Animal Observed binary scale 0.26 (±0.07) 0.04 (±0.02)
Underlying liability scale 0.42 NA
Sire-dam Observed binary scale 0.23 (±0.05) 0.03 (±0.02)
Underlying liability scale 0.37 NA
Probit-link scale 0.33 (±0.07) 0.05 (±0.03)
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wide level, whereas the QTL on chromosomes 3 and 7 were signiﬁcant
at the chromosome-wide level. The QTL on chromosome 3 was
conﬁrmed with a dam-linkage analysis using the sparse SNP panel,
which also identiﬁed a further QTL on chromosome 4 (both were
signiﬁcant at the chromosome-wide level). The sib-pair (SP) analysis
using the same sparse SNP panel also identiﬁed the QTL on
chromosomes 3 and 4, with the QTL on chromosome 4 reaching
genome-wide signiﬁcance (Table 2).
To estimate the position of QTL on the chromosomes, a further 28
SNPs were genotyped across the four chromosomes for which QTL
were identiﬁed at the chromosome- or genome-wide signiﬁcance level
(Table 2), and these were then used in a dam-linkage HS analysis. This
conﬁrmed and positioned QTL on chromosomes 3 and 4 towards
the ends of the linkage maps, at map positions 135 cM and 74 cM,
respectively (Table 2; chromosome 3 position shown in Figure 2a).
The SP analysis using the denser set of markers conﬁrmed the QTL on
chromosomes 3 and 4 (both reached chromosome-wide signiﬁcance),
and estimated QTL locations overlapped with those obtained from the
HS analysis (chromosome 3 at 129 cM and chromosome 4 at 75 cM).
The conﬁdence interval for the QTL on chromosome 4 was narrowed
to 13 cM in the SP analysis, using bootstrapping.
Overall, the four QTL were individually estimated to explain
between 4 and 9% of the within-family variance for PD resistance
(Table 2). The proportion of within family variance estimated using
the sire-based linkage analysis only were comparable between the three
sire-segregating QTL. The QTL on chromosome 3 was the only
QTL identiﬁed in both the sire- and dam-based linkage analysis, and
explained the highest proportion of within-family variance for
resistance when both sire- and dam-based analyses were considered
together.
In POP 2, one genome-wide signiﬁcant QTL was detected in both
the HS and SP analyses, localised at the distal end of chromosome 3
based on the map by Lien et al. (2011) (Table 2 and Figures 2b and c).
The QTL peaks in the SP and HS analyses were concordant (QTL
peaks at 61 cM and 72 cM, respectively; Table 2). The apparent 10 cM
difference in QTL peak in the two analyses is likely to be a result of the
SP analysis not allowing identical map locations for adjacent markers.
In these cases, a small arbitrary genetic distance was inserted, which
resulted in an expansion of the overall map. In the HS analysis, the
QTL on chromosome 3 explained ~23% of the within-family variance
for survival, and was found to be segregating in 18 of 99 parents. The
most likely position of the QTL was towards the distal end of the
chromosome (Figure 2c). In addition to the genome-wide signiﬁcant
QTL on chromosome 3, two suggestive, chromosome-wide signiﬁcant
QTL were detected, on chromosome 2 (HS and SP) and chromosome
14 (SP) (Table 2).
Across both populations and all analyses, chromosome 3 was
identiﬁed as containing a resistance QTL. To conﬁrm that this QTL
maps to the same region of chromosome 3 in both populations,
common markers between the linkage maps used in QTL mapping in
the two populations were identiﬁed, and used as anchors to orientate
the maps relative to each other. Likelihood proﬁle maps were plotted
to demonstrate that the QTL mapped to the same region of
chromosome 3 (Figure 2e). This suggests a common QTL-
inﬂuencing resistance in both populations, and across both the fry
and post-smolt stages of the Atlantic salmon lifecycle.
Table 2 Summary of genome-wide and chromosome-wide signiﬁcant QTL across both populations and all linkage analyses
Population Analysis Chromosome No. of SNPs
Map
length (cM)
QTL
position (cM) F-statistic
Chromosome-wide
F-stat threshold
(Po0.05/0.01)
No. of segregating
parents
Proportion of
within family
variance
explained (%)
POP 1 Sparse Sire 3 1 NA NA 2.3a 1.7/2.1 3 7.6/9.2b
7 3 NA NA 2.2a 1.6/2.0 3 7.4/5.5b
23 2 NA NA 2.3c 1.7/2.0 2 8.3/4.8b
HS Sparse Dam 3 1 NA NA 1.6a 1.5/1.8 5 7.6/9.2b
4 2 NA NA 1.8a 1.5/1.7 6 NS/6.3b
Dense Dam 3 12 135 135 1.6a 1.5/1.7 5 NA
4 6 77 74 1.5a 1.4/1.7 6 NA
7 7 65 NA 1.1NS 1.5/1.7 4 NA
23 11 71 NA 0.8NS 1.5/1.7 3 NA
Sparse 3 1 NA NA 9.7a 3.2/6.6 NA NA
SP 4 2 NA NA 20.9c 4.9/9.4 NA NA
Dense 3 12 135 129 12.5a 6.7/11.5 NA NA
4 6 77 75 10.1a 6.3/11.5 NA NA
POP 2 HS 3 234 123 61d 2.3*,a 1.4/1.5 18 23.0
2 241 122 65d 1.5a 1.4/1.5 10 10.0
SP 3 234 123 72d 80.7c 7.5/11.7 NA NA
2 241 122 57d 12.9a 7.0/11.7 NA NA
14 206 69 14d 18.3a 7.4/12.0 NA NA
Abbreviations: cM, centiMorgan; HS, half-sibling; NS, not signiﬁcant, QTL, quantitative trait locus; SP, sib-pair.
aChromosome-wide signiﬁcant.
bProportion of within family variance explained estimated using sire only/sire+dam sparse SNP analysis.
cGenome-wide signiﬁcant.
dBased on a new map constructed for Chr03 using the genotype data in this study.
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Association analysis
In POP 2, all included post-smolts were genotyped using the 6 K
Atlantic salmon SNP array. To detect SNPs showing signiﬁcant
association to PD resistance in POP 2, a genome-wide association
analysis was performed, using 4178 quality-ﬁltered SNPs. Of these, 184
SNPs reached nominal signiﬁcance Po0.05, of which 20% were found
on chromosome 3 (Figure 3). After permutation testing to estimate
genome-wide signiﬁcance levels, two SNPs were signiﬁcant (adjusted
Po0.01). Both SNPs are located on chromosome 3, the most
signiﬁcant at 120 cM (ESTV_18493_1052) and the second at 113 cM
(ESTNV_29410_233), using the map generated for this chromosome
by the data in this study. In the published linkage map, the female/
male positions for these two SNPs are 111/58 cM and 104/57 cM,
respectively (Lien et al., 2011). In POP 1, two SNPs on chromosome 3
were also signiﬁcantly associated (Po0.001) with resistance to PD:
consensus46559_59 and consensus110127_55 at map positions 67 and
87 cM, respectively.
DISCUSSION
To explore the genetic architecture of PD resistance, two independent
populations of farmed Atlantic salmon fry and post-smolts were
challenged using SAV3, the most prevalent strain of SAV in Norway.
Using the binary trait of mortality/survival from the challenge
experiments, moderate-to-high heritability estimates of resistance to
PD were obtained (~0.5 for fry in POP 1 and ~ 0.4 for post-smolt in
POP 2). Following this, QTL mapping studies in the two populations
identiﬁed six putative resistance QTL. The most convincing and
robust evidence for a QTL in both populations was detected near the
distal end of chromosome 3. This QTL explained the largest
proportion of within-family variance for PD resistance in both
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populations, and markers showing population-level association with
PD resistance were identiﬁed close to the QTL peak.
The high heritability obtained from fry in POP 1 in this study is
similar to some of the larger estimates reported for disease resistance
traits in Atlantic salmon (for example, 0.55 for infectious pancreatic
necrosis and 0.51–0.62 for furunculosis (Kjøglum et al., 2008;
Drangsholt et al., 2011)). Notably, this estimate is almost double than
that obtained by Norris et al. (2008) (h2= 0.21), where a natural SAV
outbreak in farmed Atlantic salmon smolts was analysed. The
heritability estimate obtained in post-smolts for POP 2 in the current
study is moderate-to-high (0.33 from the probit analysis, ~ 0.4 when
transformed from linear model analysis), but still larger than the
estimate obtained by Norris et al. (2008). Despite the differences
(including life stage, challenge model and population origins) between
the three populations (POP 1 and POP 2 in this study, and the
population in Norris et al. (2008)), there is consistent evidence for
high heritable variation in PD resistance. This, combined with the
large variation in mortality seen in both populations in this study
(POP 1 and POP 2), strongly suggests that selection for PD resistance
is plausible.
In both POP 1 and POP 2, subsets of families showing intermediate
levels of mortality were deliberately chosen for QTL analysis
from a larger set of families. This increases the power of QTL
detection by linkage analysis by increasing the likelihood of having
QTL-segregating parents in the data set, and reduces the false-positive
rate in genome-wide association analysis by minimising
spurious associations resulting from phenotypically extreme families
(Darvasi and Soller, 1992; Hayes et al., 2009). The two studies did,
however, differ in the marker genotyping strategy and hence also in
the QTL mapping approaches, as described above. In simple terms, in
POP 1 the experiment was designed to exploit the sex-speciﬁc
recombination rates to reduce the number of individual SNPs required
(and therefore increase efﬁciency), whereas in POP 2 this was
unnecessary because all animals were genotyped for a SNP chip
(Lien et al., 2011). However, despite the differences in genotyping
technologies and methods of analysis within (HS vs SP) and between
the populations, one single QTL on chromosome 3 was repeatedly
identiﬁed as chromosome- or genome-wide signiﬁcant in all analyses.
This not only provides validation and strong support for this QTL, but
also highlights the efﬁcacy of both genotyping and mapping
approaches.
Natural outbreaks of PD are observed almost exclusively at
the post-smolt stage of the Atlantic salmon lifecycle. Although viral
isolates have been detected in freshwater, no outbreaks of PD in the fry
stage have been recorded (Jansen et al., 2010b). The practicality of
large-scale challenge experiments at the fry stage of the salmon
lifecycle has meant that fry challenges can be used as a model for
post-smolt PD outbreaks (Cano et al., 2014). However, differences in
behaviour, environment and physiology between the freshwater
and marine stages of the salmon lifecycle mean that the genetic
architecture of PD resistance could potentially differ between the two
life stages.
The identiﬁcation of the same QTL on chromosome 3 in both the
fry and post-smolt populations in this study suggests that similar
biological mechanisms are likely to be inﬂuencing this component of
resistance to PD in both lifecycle stages. If the causal factors underlying
the QTL on chromosome 3 are related to an immune response, they
are likely to be part of a general innate immune response against SAV,
as the adaptive immune response is undeveloped at the juvenile stage.
A signiﬁcant induction of innate genes, such as IFN and Mx, has been
implicated in the response of salmon to SAV challenge (Grove et al.,
2013; Herath et al., 2013). Alternatively, the causal factor(s) underlying
the resistance QTL may affect variation in the ability of the host to
block the progression of the viral lifecycle. The concordance of the
QTL between the two populations (one intraperitoneally injected and
the other given a form of bath challenge) suggests that the main
underlying factors are unlikely to be related to barrier function.
However, the lack of concordance between the other QTL identiﬁed in
the two studies suggests that there may also be factors underlying
genetic resistance that are unique to each lifecycle stage and challenge
model.
MAS has been successfully applied in aquaculture breeding,
including for female monosex Chinook salmon production (Devlin
et al., 1991), for resistance to lymphocystis disease in Japanese
ﬂounder (Fuji et al., 2007), and for resistance to infectious pancreatic
Figure 3 Genome-wide association analysis in POP 2. Manhattan plot
depicting P-values (corrected for inﬂation) from the 1-d.f. test for association
between SNP and trait (binary survival) for (a) the whole genome (29
chromosomes) and (b) chromosome 3.
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necrosis in Atlantic salmon (Houston et al., 2008; Moen et al., 2009;
Houston et al., 2010). In this study, SNPs in putative linkage
disequilibrium with the PD resistance QTL on chromosome 3 have
been identiﬁed, and are currently being employed in MAS to select for
improved PD resistance in commercial Atlantic salmon (H Bakke,
pers. comm.). However, it is possible that these markers are a
considerable distance from the causative gene and/or mutation.
Further reﬁnement of the QTL position and eventual identiﬁcation
of candidate genes or mutations would be advantageous for both
applied MAS (more accurate marker predictors of QTL genotype) and
our understanding of the biological basis of genetic resistance to PD.
This could be achieved by genotyping and testing a much higher
number of SNPs in the region of the QTL, for example using a high-
density SNP array (Houston et al., 2014), or by re-sequencing of
alternate homozygotes at the QTL on chromosome 3. In addition,
positional and functional candidate genes for the QTL can be
generated by taking a comparative genomics approach, as demon-
strated for Infectious Salmon Anemia resistance (Li et al., 2011), or by
interrogation of the Atlantic salmon genome (Davidson et al., 2010) as
its assembly and annotation improves.
CONCLUSIONS
Two independent populations of Atlantic salmon were challenged
with SAV3; one as fry in freshwater and the other as post-smolts in
marine water. A moderate-to-high heritability for resistance to PD
was estimated in both populations (fry h2 ~ 0.5; post-smolt
h2 ~ 0.4), demonstrating the feasibility of family selection for PD
resistance. QTL mapping analyses identiﬁed six chromosomes
(2, 3, 4, 7, 14 and 23) harbouring putative PD resistance QTL
across both populations. A QTL on the distal end of chromosome 3
was identiﬁed in all analyses and explained the largest proportion of
within-family variation in resistance in both populations. The
detection of this QTL across both the fry and post-smolt stages
suggests a common mechanism for PD resistance at both lifecycle
stages. SNPs on this chromosome were signiﬁcantly associated with
PD resistance at a population level, and these are currently being
implemented in MAS for improved PD resistance. Further reﬁne-
ment of this result may lead to more effective marker-based
selection and an improved understanding of the host regulation
of resistance to this important disease.
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